

The FlightBridgeED Podcast
FlightBridgeED
The FlightBridgeED Podcast provides convenient, easy-to-understand critical care medical education and current topics related to the air medical industry. Each topic builds on another and weaves together a solid foundation of emergency, critical care, and prehospital medicine.
Episodes
Mentioned books

Nov 9, 2026 • 35min
MDCAST | Under Pressure: The Balloon Pump Breakdown
In this episode of the FlightBridgeED MDCast, Dr. Mike Lauria explores the role of intra-aortic balloon pumps (IABPs) in managing cardiac dysfunction and cardiogenic shock, with a particular focus on critical care transport. The discussion begins with a review of cardiogenic shock physiology, emphasizing the dangerous cycle of declining cardiac output, reduced coronary perfusion, worsening myocardial function, and progressive end-organ dysfunction. While intra-aortic balloon pumps have historically been used to support patients in cardiogenic shock, their relatively limited ability to increase cardiac output makes them less effective in profound or rapidly deteriorating shock. However, they may still provide meaningful support in select populations, including patients with acute decompensated heart failure, mitral regurgitation, or temporary myocardial dysfunction following cardiac surgery or coronary intervention.
The episode explains the fundamental mechanism of intra-aortic balloon counterpulsation, which relies on precisely timed balloon inflation and deflation to improve cardiovascular performance. Positioned within the descending thoracic aorta, the balloon inflates during diastole, increasing diastolic aortic pressure and improving coronary artery perfusion. Immediately before systole, the balloon rapidly deflates, reducing left ventricular afterload and myocardial oxygen demand while modestly increasing stroke volume and cardiac output. Although these physiological benefits are well established, large clinical trials have not demonstrated a consistent mortality benefit in patients with cardiogenic shock. Nevertheless, IABPs remain commonly encountered in critical care transport because of their availability, relative simplicity, and potential usefulness as temporary support or a bridge to more definitive therapies.
Dr. Lauria emphasizes a systematic approach to bedside assessment, beginning with the patient's overall clinical condition before evaluating the device itself. Transport clinicians should assess hemodynamics, oxygenation, perfusion, and other critical interventions before examining balloon pump function. Device assessment includes confirming appropriate diastolic augmentation, evaluating assisted end-diastolic pressure, verifying catheter position on chest radiography, and inspecting the insertion site for bleeding or catheter migration. Proper inflation and deflation timing are essential because incorrect timing can increase ventricular workload or reduce coronary perfusion. Although modern IABP consoles generally manage timing effectively through automated triggering, clinicians should still recognize abnormalities and understand their physiological consequences.
The discussion concludes with complications and operational considerations associated with transporting patients receiving IABP support. Significant concerns include vascular access hemorrhage, limb ischemia, balloon rupture, helium loss, and complete device malfunction. Blood appearing within the helium tubing is particularly concerning because it may indicate balloon rupture and requires immediate intervention according to device-specific protocols. Transport teams must also ensure adequate battery capacity and helium reserves, particularly during air medical transport, where altitude changes can increase helium consumption through system recalibration. Careful patient positioning, prevention of excessive hip and knee flexion, and protection of the catheter insertion site are essential. Ultimately, safe IABP transport requires a solid understanding of counterpulsation physiology, consistent patient-centered assessment, familiarity with equipment operation, and early recognition of potentially life-threatening complications.
Key Points
Counterpulsation improves coronary perfusion and reduces cardiac workload. Balloon inflation during diastole increases coronary perfusion pressure, while rapid deflation before systole reduces left ventricular afterload and myocardial oxygen demand. IABPs provide modest circulatory support and are not appropriate for every case of cardiogenic shock. They typically increase cardiac output by approximately 0.5–1 L/min and may be most useful in select patients requiring temporary support while myocardial function recovers or definitive treatment is arranged.
Effective assessment begins with the patient, not the machine. Clinicians should evaluate hemodynamic stability, oxygenation, and peripheral perfusion before confirming appropriate balloon augmentation, deflation, catheter position, and vascular access integrity. Bleeding, limb ischemia, balloon rupture, and device malfunction are major transport complications. Frequent access-site inspections, distal pulse assessments, and monitoring for blood in the helium tubing are essential for identifying complications before they become life-threatening.
Transport preparation must account for equipment limitations and patient movement. Adequate battery reserves, supplemental helium, secure catheter placement, and appropriate patient positioning are critical, particularly during air transport when altitude-related recalibration can increase helium consumption.

Oct 15, 2026 • 45min
MDCAST | A Bridge Over Troubled Ventricles
In this episode of the FlightBridgeED MDCast, Dr. Mike Lauria explores the role of Impella devices in managing cardiogenic shock, with a particular focus on critical care transport. Impella devices provide temporary mechanical circulatory support (MCS) for patients experiencing severe cardiac dysfunction. They are commonly used as a bridge to recovery, high-risk cardiac interventions, surgical procedures, heart transplantation, or further clinical decision-making. The episode reviews the progression of cardiogenic shock, emphasizing how decreased cardiac output, inadequate coronary perfusion, and compensatory vasoconstriction can create a dangerous cycle of worsening myocardial function, pulmonary congestion, and multiorgan failure.
The Impella is a percutaneous microaxial blood pump that moves blood directly from the left ventricle into the aorta, providing three major physiological benefits: increased cardiac output, left ventricular unloading, and improved coronary perfusion. By reducing ventricular pressure, volume, and wall stress, the device decreases myocardial oxygen demand while improving systemic circulation. Dr. Lauria also discusses the evolving evidence supporting Impella use, highlighting the landmark DanGer Shock trial. This randomized study demonstrated a significant reduction in six-month mortality among selected patients with acute myocardial infarction complicated by cardiogenic shock who received early Impella CP support. However, these benefits must be weighed against complications such as major bleeding, limb ischemia, and device-related problems.
A substantial portion of the discussion focuses on the practical assessment and management of patients receiving Impella support during transport. Dr. Lauria emphasizes that clinicians must assess the patient before focusing on the device, evaluating hemodynamic stability, respiratory status, perfusion, and signs of ongoing ischemia. Device assessment includes reviewing the automated Impella controller, confirming appropriate aortic and ventricular pressure waveforms, evaluating motor current oscillations, and monitoring pump flow and purge pressures. Particular attention must be directed toward the vascular access site, where catheter movement can result in significant hemorrhage, and toward the affected extremity for evidence of compromised distal perfusion. Other important complications include device malposition and suction events, which may result from inadequate preload, right ventricular failure, or improper catheter positioning.
The episode concludes with considerations for safely transporting patients supported by Impella devices, including power management, equipment accessibility, patient positioning, and emergency response. Transport teams must ensure adequate battery reserves, secure the controller where it remains visible and accessible, protect the catheter and vascular access site, and minimize excessive patient movement. Although patients with Impella support can undergo conventional resuscitation, cardiac arrest requires additional attention to pump settings and potential device displacement. Ultimately, successful Impella transport requires an understanding of cardiogenic shock physiology, familiarity with device function, careful patient assessment, and proactive recognition of complications.
Key Points
Impella devices provide temporary mechanical circulatory support. They serve as a bridge to myocardial recovery, definitive cardiac interventions, transplantation, or further clinical decision-making in patients with significant cardiac dysfunction.
Impella support improves cardiovascular physiology through three primary mechanisms. The device increases cardiac output, unloads the left ventricle to reduce myocardial workload, and improves coronary perfusion. The DanGer Shock trial demonstrated a mortality benefit in a carefully selected population with myocardial infarction-related cardiogenic shock.
Patient assessment takes priority over device assessment. Transport clinicians should evaluate hemodynamics, oxygenation, perfusion, and clinical stability while monitoring pump flow, pressure waveforms, motor current, and purge system performance.
Bleeding, limb ischemia, device malposition, and suction events are critical complications. Vascular access sites require frequent inspection, distal perfusion must be monitored, and abnormal device waveforms or alarms should prompt immediate evaluation.
Safe transport requires meticulous equipment and patient management. Teams must maintain reliable electrical power, ensure the controller remains accessible, protect the insertion site from movement or compression, and be prepared to perform resuscitation while accounting for the Impella device.

Jul 22, 2026 • 38min
The Nightmare Series Case: The Hypoxic Spiral
Kari Young, an experienced paramedic renowned for frontline airway and critical-care insights, joins to unpack a rapid hypoxic spiral case. They walk through assessment clues, the COPD vs CHF dilemma, tough triggers for intubation, and the resuscitative vs rapid RSI debate. Expect frank discussion of post-intubation crashes, ventilation strategy choices, and defending on-scene resuscitation.

Jun 25, 2026 • 1h 20min
The Nightmare Series Case: The Diagnostic Mindfield
Kari Young, an advanced practice paramedic and educator, guides a clinical case review of a very sick dialysis patient. They unpack multiple overlapping problems and the scene challenges, airway and resuscitation choices, and how cognitive bias can derail diagnosis. Short, sharp lessons on managing complex prehospital critical care.

Jun 18, 2026 • 27min
MDCAST | ROSC and Roll: Post-Arrest Care in Transport
Post-ROSC transport demands sharp priorities: stabilize the heart, uncover the arrest’s cause, protect the brain, and anticipate re-arrest. Explore airway decisions, vasopressors, repeat ECGs, ultrasound, ventilation, sedation, and neurologic exams, plus the ALIVE-12 checklist for moving fragile patients safely toward definitive care.

Jun 18, 2026 • 25min
MDCAST | The CHF Slide
A deceptively stable patient with pulmonary edema may already be sliding toward cardiogenic shock. This discussion explores recognizing early left-heart failure in transport, using ultrasound and clinical signs, and supporting the failing ventricle with nitroglycerin, CPAP or BiPAP, diuresis, and dobutamine. It also covers coaching anxious patients through noninvasive ventilation and responding when deterioration becomes unmistakable.

May 19, 2026 • 51min
MDCAST: The Stubborn Lethality of Cardiogenic Shock
A deep dive into why cardiogenic shock still carries high mortality and how changing patient populations drive rising cases. The SCAI A–E framework is highlighted as a tool to spot severity early. Practical transport-focused topics include MAP support, oxygenation strategies, volume and inotrope decisions, optimizing mechanical support, and the logistics of fast, safe transfers to specialized centers.

May 19, 2026 • 32min
MDCAST: Right Heart Failure: The Hidden Critical Care Problem
A focused dive into why the right ventricle is uniquely vulnerable to sudden pressure rises and how that can trigger a rapid hemodynamic collapse. The conversation highlights the classic “RV spiral of death,” bedside clues like CT and echo signs, and a practical five-step resuscitation framework. Specific strategies include blood pressure support, careful preload management, reducing pulmonary afterload, and targeted therapies such as inhaled vasodilators and selective inotropes.

May 8, 2026 • 34min
FASTReplay: Double Feature - Brittney Bernardoni + Elizabeth Garcher
This week’s FAST Replay is a double feature! Two talks that tackle high-stakes medicine from completely different angles, but with the same underlying theme: thinking differently when the usual approach isn’t enough.
First up, Brittany Bernardoni takes us into the rapidly evolving world of Extracorporeal Cardiopulmonary Resuscitation (ECPR). From the limitations of conventional CPR to the growing use of ECMO in cardiac arrest, this session explores what may become the next major leap forward in resuscitation care. Brittany walks through the physiology, patient selection, timing, and the real-world programs already bringing ECPR directly to patients in the field.
Then, Elizabeth Garcher dives into one of the most intimidating areas in prehospital and critical care medicine: pregnancy-related emergencies. This talk focuses on “errors of omission.” The treatments clinicians hesitate to give because of fear of harming the baby, even when delaying care, can seriously harm both patients. From airway changes and hypertensive emergencies to eclampsia, DKA, blood products, and seizure management, this session is packed with practical pearls and critical reminders for managing pregnant patients in the field.
Two completely different topics. Two incredibly practical talks.
One common thread: understanding the physiology well enough to act decisively when it matters most.

Apr 27, 2026 • 20min
FASTReplay: Let The Literature Illuminate Your Practice - featuring Jeff Jarvis
We’re continuing our FAST Replay series, bringing you full sessions recorded live from past FAST conferences as we build toward FAST26: Austin. This episode features Jeff Jarvis and covers a wide range of topics that directly address how we practice in EMS.
From trauma care to airway to cardiac arrest, this session walks through current position statements and evolving recommendations, including:
• Blood product use in trauma
• How to approach traumatic (circulatory) arrest
• Pneumothorax and chest decompression decisions
• Postpartum hemorrhage and hypertension management
• Airway timing and first-pass success
• And where some of our long-standing practices don’t hold up to the evidence
More than anything, this talk highlights a core idea: not everything we do in EMS is built on strong evidence, and we need to be willing to question and refine our approach as new data emerge.
FAST26 is coming to Austin this year on May 27 - 29, 2026. We are co-locating with EMS World Live, bringing together the entire EMS community with FAST26: Austin and EMS World Live Austin, giving you the very best of every possible aspect from basics to critical care to administration!
👉 Learn more or grab your spot at https://fbefast.com


